Statement from the Tánaiste on new US Tariffs

Following the announcement by President Trump overnight of new US tariffs including on patented pharmaceuticals, Tánaiste Simon Harris said: “We will be studying the impact of this announcement, which includes a number of exemptions, together with EU colleagues.

“I want to stress, however, that the EU and US Joint Statement issued on 21 August last made absolutely clear that any new tariffs announced by the US on pharmaceuticals under its Section 232 investigation would be capped at 15% for pharma products being exported by the EU.

“This remains the case and underlines again the value of the agreement reached last month.

“Returning home after a series of valuable meetings in both New York and Washington, where I met with US Secretary of Commerce, Howard Lutnick, I remain as convinced as ever of the mutually beneficial nature of the dynamic, two way economic partnership between Ireland and the US as well as between the EU and the US.”

ENDS

Press Office

26 September 2025